The Global Elispot and Fluorospot Assay Market is valued at USD 432 Million in 2024 and is projected to reach a value of USD 2155 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 15.75% ...

SNS Insider Unveils Strategic Insights into the U.S. ELISpot and Fluorospot Assay Market’s Rapid Growth—Valued at USD 79.68 Million in 2023—While the U.S. Commands Over 40% of the Global ...

The global ELISpot and FluoroSpot Assays market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3% during the forecast period.

Kobe University and Sysmex Corporation have been engaged in joint research on the ELISPOT method, a new blood test for identifying COVID-19. This method makes it possible to detect the immune ...

Kobe University and Sysmex Corporation have been engaged in joint research on the ELISPOT method, a new blood test for identifying the novel coronavirus disease (COVID-19).

Background: P10-1 (NCT01338012) is a study of sipuleucel-T, an autologous cellular immunotherapy, in men with mCRPC previously treated with sipuleucel-T in PROTECT (NCT00779402). This preliminary ...

Elispot and Fluorospot Market Elispot and Fluorospot Market Dublin, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The "ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer ...